Area of research
Oncology · Physiology
Research interest
Research interests include Medicine, Cetuximab, Clinical endpoint, KRAS, Cohort, and Internal medicine.
Cetuximab Plus Mfolfox-6 As First-Line Therapy for Patients with Kras Wild-Type Unresectable Colorectal Liver-Limited Metastases: an Open, Non-Randomized, Multicenter Phase Ii Clinical Trial (Clime Study)
Quantitative Analyses of Early Tumor Shrinkage on Clinical Outcome in an Open, Non-Randomized, Multicenter Phase Ii Clinical Trial (Clime Study)